![Geoffrey von Maltzahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey von Maltzahn
Profilo
Geoffrey von Maltzahn was the founder of Expedition Medicines, Inc. (2022), serving as Director; Seres Therapeutics, Inc. (2010), serving as Chief Technology Officer; Axcella Health, Inc. (2008), serving as Vice President-Discovery; Indigo Ag, Inc. (2013), serving as Chief Innovation Officer & Director; Kaleido Biosciences, Inc. (2015), serving as Director; Generate Biomedicines, Inc. (2018), serving as Director;.
Mirai Bio (2021), serving as Chief Executive Officer; Tessera Therapeutics, Inc. (2018), serving as Chairman; and Quotient Therapeutics Ltd. (2022), serving as Chairman.
Dr. von Maltzahn is also the founder of Resonance Therapeutics,Sienna Biopharmaceuticals, Inc...
Dr. von Maltzahn currently works as General Partner at Flagship Pioneering, Inc. since 2009.
Former positions include President, Chief Executive Officer & Director at Cobalt Biomedicine, Inc.; Independent Director at Sana Biotechnology, Inc. from 2019 to 2021; and Vice President-Corporate Development at Essentient, Inc. Education includes undergraduate and doctorate degrees from Massachusetts Institute of Technology and a graduate degree from the University of California San Diego.
Posizioni attive di Geoffrey von Maltzahn
| Società | Posizione | Inizio |
|---|---|---|
Resonance Therapeutics
 Resonance Therapeutics Medical/Nursing ServicesHealth Services Develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics | Fondatore | 17/09/2009 |
Indigo Ag, Inc.
 Indigo Ag, Inc. Develops biological and digital technologies | Fondatore | 01/01/2013 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Investitore di Private Equity | 01/01/2009 |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. Develops therapeutics and novel medicines | Fondatore | 01/01/2018 |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Fondatore | 01/01/2018 |
Precedenti posizioni note di Geoffrey von Maltzahn
| Società | Posizione | Fine |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Fondatore | 15/03/2022 |
| SANA BIOTECHNOLOGY, INC. | Direttore/Membro del Consiglio | 01/09/2021 |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Engages in developing therapeutic based drugs | Amministratore Delegato | 01/02/2019 |
Essentient, Inc.
 Essentient, Inc. Develops transforming global nutrition | Corporate Officer/Principal | 17/02/2014 |
| ░░░░ ░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Geoffrey von Maltzahn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Resonance Therapeutics
Resonance Therapeutics Medical/Nursing ServicesHealth Services Develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics | Health Services |
Essentient, Inc.
Essentient, Inc. Develops transforming global nutrition | |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. Develops novel treatments for diseases related to the human microbiome | |
Axcella Health, Inc.
 Axcella Health, Inc. Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | |
Indigo Ag, Inc.
Indigo Ag, Inc. Develops biological and digital technologies | |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Engages in developing therapeutic based drugs | |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. Develops therapeutics and novel medicines |
